Catalyst Wire Dossier Catalyst Wire Dossier

Dihydroergotamine mesylate

Dihydroergotamine Mesylate · Provepharm Inc.
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Dihydroergotamine mesylate, covering 2013-10-22 to 2025-02-26. Get the full timeline:

Most recent: FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Somerset Therapeutics, LLC)

See pricing